Sagent docetaxel injection, used in veterinary clinics
Recall announced May 29, 2024 by Sagent Pharmaceuticals, posted by the U.S. Food and Drug Administration (FDA). Reason: Potential presence of particulate matter. It affects dogs and cats. The agency has not closed this recall.
- Brands
- Sagent
- Where sold
- Distributed nationwide by Sagent Pharmaceuticals from October 11, 2023 to April 11, 2024.
- Last updated
- November 20, 2026
Products included
- Docetaxel Injection, USP (NDC 25021-254-16), 160 mg/16 mL (10 mg/mL) (F1030001; Best by 12/2024)
- Docetaxel Injection, USP (NDC 25021-254-08), 80 mg/8 mL (10 mg/mL) (F1040001; Best by 12/2024)
Read the official notice. Always compare the codes on your package with the official notice. It is the final word.
Has your pet used this product and seems unwell? Call your veterinarian or an emergency animal hospital now.
